Community

Affymetrix Community - View all communties

Welcome to the Affymetrix Community

The Affymetrix communities bring together a wealth of news, helpful information, expert advice, and real time content— shared in a highly interactive environment.

Affymetrix Community - View the Communities
Affymetrix Cancer Community - User Group Meeting Presentations

Scientific Communities

Affymetrix is dedicated to providing innovative genomic analysis tools and education resources for the life science research community.

Affymetrix Scientific Communities
Scientist Spotlight - Joshua Schiffman, MD

Featured Researchers

Discover how researchers are using Affymetrix products and services to power their experiments in the Featured Researchers. This community features scientists who will share their work with you through hands-on activities and conversation. Learn how scientists detect cancer-causing genes and more.

Featured Researchers
Featured Social Network - Affymetrix Genomic Applications

Participate, Connect, and Share

Follow what others are saying about us on Twitter and Facebook.

The Affymetrix communities bring together a wealth of news, helpful information, expert advice, and real time content— shared in a highly interactive environment.

Affymetrix Connect - Participate, Connect and Share
Scientific Publications - Search Database of Publications

Scientific Publications

Search our database of 24506 scientific publications that use Affymetrix technology.

The database is updated daily with new publications from core journals. Our criteria for inclusion is peer-reviewed, final publications.

Scientific Publications - Search Database of Publications

Scientific Communities

Researchers

Featured Publications

  • A Small Terminal Deletion 11q in a Boy Without Jacobsen Syndrome: Narrowing the Critical Region for the 11q Jacobsen Syndrome Phenotype
    Evers, C.; Janssen, J. W. G.; Jauch, A.; Bonin, M.; Moog, U. American Journal of Medical Genetics Part a 158A(3), 680-4, 2012 PubMed
  • Whole-Exome Sequencing Identifies Mutations in GPR179 Leading to Autosomal-Recessive Complete Congenital Stationary Night Blindness
    Audo, I.; Bujakowska, K.; Orhan, E.; Poloschek, C. M.; Defoort-Dhellemmes, S.; Drumare, I.; Kohl, S.; Luu, T. D.; Lecompte, O.; Zrenner, E.; Lancelot, E.; Antonio, M.; Germain, A.; Michiels, C.; Audier, C.; Letexier, M.; Saraiva, J. P.; Leroy, B. P.; Munier, F. L.; Mohand-Said, S.; Lorenz, B.; Friedburg, C.; Preising, M.; Kellner, U.; Renner, A. B.; Moskova-Doumanova, V.; Berger, W.; Wissinger, B.; Hame, C. R.; Schorderet, D. F.; De Baere, E.; Sharon, D.; Banin, E.; Jacobson, S. G.; Bonneau, D.; Zanlonghi, X.; Le Meur, G.; Casteels, L.; Koenekoop, R.; Long, V. W.; Meire, F.; Prescott, K.; de Ravel, T.; Simmons, I.; Nguyen, H.; Dollfus, H.; Poch, O.; Leveillard, T.; Nguyen-Ba-Charvet, K.; Sahel, J. A.; Bhattacharya, S. S.; Zeitz, C. American Journal of Human Genetics 90(2), 321-30, 2012 PubMed
  • Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma
    Schwartzentruber, J.; Korshunov, A.; Liu, X. Y.; Jones, D. T. W.; Pfaff, E.; Jacob, K.; Sturm, D.; Fontebasso, A. M.; Quang, D. A. K.; Toenjes, M.; Hovestadt, V.; Albrecht, S.; Kool, M.; Nantel, A.; Konermann, C.; Lindroth, A.; Jaeger, N.; Rausch, T.; Ryzhova, M.; Korbel, J. O.; Hielscher, T.; Hauser, P.; Garami, M.; Klekner, A.; Bognar, L.; Ebinger, M.; Schuhmann, M. U.; Scheurlen, W.; Pekrun, A.; Fruehwald, M. C.; Roggendorf, W.; Kramm, C.; Duerken, M.; Atkinson, J.; Lepage, P.; Montpetit, A.; Zakrzewska, M.; Zakrzewski, K.; Liberski, P. P.; Dong, Z. F.; Siegel, P.; Kulozik, A. E.; Zapatka, M.; Guha, A.; Malkin, D.; Felsberg, J.; Reifenberger, G.; von Deimling, A.; Ichimura, K.; Collins, V. P.; Witt, H.; Milde, T.; Witt, O.; Zhang, C. D.; Castelo-Branco, P.; Lichter, P.; Faury, D.; Tabori, U.; Plass, C.; Majewski, J.; Pfister, S. M.; Jabado, N. Nature 482(7384), NPG, 2012 PubMed

Register for a Free Cancer Cell Webinar

Circulating Tumor Cells

Wednesday, May 2, 2012
1:00 EDT, 6pm GMT

Archived Webinars

Warning! The earliest signals for cancer - miRNA regulation

Featured Social Network

Genomic Applications

Covering personalized medicine, cancer research, pharmacogenomics, and more